Decreased melatonin nocturnal concentrations in hemodialyzed patients

Neuroendocrinology Letters

Volumn 26, Issue 6, 2005, Pages 653-656

  Karasek, Michal ^a,b   Szuflet, Adam ^c   Chrzanowski, Witold ^a   Zylinska, Krystyna ^a   Swietoslawski, Jacek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^c M Kopernik Hospital   (Poland)

Author keywords

Circadian rhythm; End stage renal disease; Hemodialysis; Melatonin

Indexed keywords

MELATONIN;

ADULT; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY FAILURE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HEMODIALYSIS; HUMAN; MALE; STATISTICAL ANALYSIS; VOLUNTEER;

EID: 33645013699     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Arendt J. Melatonin and the mammalian pineal gland. London: Chapman and Hall; 1995.
2. Esforzado Armengol N, Cases Amenos A, Bono Illa M, Gaya Bertran J, Calls Ginesta J, Rivera Fillat F. Autonomic nervous system and adrenergic receptors in chronic hypotensive haemodialysis patients. Nephrol Dial Transplant 1997; 12:939-44.
3. Ferchland A, Rettkowski O, Ponicke K, Deuber HJ, Osten B, Brodde OE. Effects of uremic plasma on alpha- and beta-adrenoceptors subtypes. Nephron 1998; 80:46-50.
4. Garcia-Petterson A, Puig-Domingo M, Webb SM. Thirty years of human pineal research: do we know its clinical relevance? J Pineal Res 1996; 20:1-6.
5. Holmes EW, Hojvat SA, Kahn SE, Bermes EW Jr. Testicular dysfunction in experimental chronic renal insufficiency: A deficiency of nocturnal pineal N-acetyltransferase activity. Br J Exp Pathol 1989; 70:349-56.
6. Karasek M. Melatonin in humans - where we are 40 years after its discovery. Neuroendocrinol Lett 1999; 20:179-88.
7. Karasek M, Szuflet A, Chrzanowski W, Zylinska K, Świetosławski J. Circadian serum melatonin profiles in patients suffering from chronic renal failure. Neuroendocrinol Lett 2002; 23(suppl. 1):97-102.
8. Lewanski R, Chrzanowski W. Assessment of autonomic nervous system by spectra analysis of hart rate and blond pressure In hemodialysed patients [(Ocena autonomicznego ukladu nerwowego za pomoca skali zmiennosci rytmu serca, cisnienia tetniczego u chorych hemodializowanych) (In Polish with English abstract)]. Pol Merkuriusz Lek 2003; 15:391-393.
9. Morin D,.Simon N, Depres-Brummer P, Levi F, Tillement JP, Urien S. Melatonin high-affinity binding to alpha-1-acid glycoprotein in human serum. Pharmacology 1997; 54:271-75.
10. Lüdemann P, Zwernemann S, Lerchl A. Clearance of melatonin and 6-sulfatoxymelatonin by hemodialysis in patients with end-stage renal disease. J Pineal Res 2001; 31:222-7.
11. Souchet T, Bree F, Baatard R, Fontenaille C, D'Athis R, Tillement JF et al. Impaired regulation of beta 2-adrenergic receptor density in mononuclear cells during chronic renal failure. Biochem Pharmacol 1986; 35:2513-9.
12. Vaziri ND, Oveisi F, Wierszbiezki M, Shaw V, Sporty LD. Serum melatonin and 6-sulfatoxymelatonin in end-stage renal disease: effect of hemodialysis. Artif Organs 1993; 17:764-9.
13. Viljoen M, Steyn ME, van Rensburg BWJ, Reinach SG. Melatonin in chronic renal failure. Nephron 1992; 60:138-43.